New SPINRAZA® (nusinersen) Data Unveiled at AAN Annual Meeting Show Continued Improvement in Motor Function for Broad Age Range and Survival Benefit for Infants
Go back to New SPINRAZA® (nusinersen) Data Unveiled at AAN Annual Meeting Show Continued Improvement in Motor Function for Broad Age Range and Survival Benefit for Infants| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 227.60 +1.24 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $226.36 | 52 Week High | $333.65 | |||
| Open | $228.27 | 52 Week Low | $223.02 | |||
| Day High | $228.92 | P/E | 29.14 | |||
| Day Low | $223.76 | EPS | $7.81 | |||
| Volume | 958,031 | |||||
| (NASDAQ: IONS) | Delayed: 44.50 +0.69 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.81 | 52 Week High | $62.68 | |||
| Open | $44.24 | 52 Week Low | $19.59 | |||
| Day High | $45.28 | P/E | N/A | |||
| Day Low | $43.62 | EPS | $0.00 | |||
| Volume | 6,202,420 | |||||

